TOKYO--(BUSINESS WIRE)--Heartseed (Heartseed Inc.), a Tokyo-based biotechnology company, today announced the successful dosing of the first patient in its domestic Phase I/II EMERALD study of HS-005, ...
Placement of a catheter for emergency peritoneal dialysis can be a relatively low-risk, low-cost procedure performed by a nephrologist at the bedside without the need for operating room resources. 1 A ...
Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress ventricular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results